Komori
Other Disclosures4890Tsubota Laboratory IncorporatedPharmaceuticals

Suggesting that differences among bone marrow donors may affect the engraftment of gut bacteria following gut microbiota transplantation

The results of a mouse study conducted by the Company with researchers from the Institute for Advanced Biosciences, Keio University, were published in the international academic journal Scientific Reports. The study showed that differences in the housing environments of bone marrow donors may be associated with the ease with which specific bacteria become established following fecal microbiota transplantation (FMT).

Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Announced details

Research results concerning fecal microbiota transplantation (FMT)
Applicable field (uses covered by this announcement)

Gut environment, immunity, eye health, healthcare solutions

Relationship between the counterparty and the company
Tsubota Laboratory Incorporated4890
Relationship with the Company

Joint research. Kazuo Tsubota (坪田一男), Representative Director and President of 坪田ラボ, participated as an author.

CounterpartyResearch group led by Specially Appointed Professor Shinya Fukuda (福田真嗣) and others at the Institute for Advanced Biosciences, Keio University

Research group led by Specially Appointed Professor Shinya Fukuda (福田真嗣) and others at the Institute for Advanced Biosciences, Keio University. Other information concerning the location, representative, capital, year of establishment and business activities is Not disclosed.

Impact on Business Performance

No impact on results is stated

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

Scientific Reports (Association between bone marrow donor origin and gut microbiota composition following fecal microbiota transplantation in mice); announcement by the research group of Specially Appointed Professor Shinya Fukuda (福田真嗣) and others at the Institute for Advanced Biosciences, Keio University

Announced details
ItemDetails
Names of Products / Services CoveredResearch results concerning fecal microbiota transplantation (FMT)
CounterpartyResearch group led by Specially Appointed Professor Shinya Fukuda (福田真嗣) and others at the Institute for Advanced Biosciences, Keio University
Counterparty overviewResearch group led by Specially Appointed Professor Shinya Fukuda (福田真嗣) and others at the Institute for Advanced Biosciences, Keio University. Other information concerning the location, representative, capital, year of establishment and business activities is Not disclosed.
Relationship with the CompanyJoint research. Kazuo Tsubota (坪田一男), Representative Director and President of 坪田ラボ, participated as an author.
Applicable areaGut environment, immunity, eye health, healthcare solutions
Impact on Business PerformanceNo impact on results is stated
SourceScientific Reports (Association between bone marrow donor origin and gut microbiota composition following fecal microbiota transplantation in mice); announcement by the research group of Specially Appointed Professor Shinya Fukuda (福田真嗣) and others at the Institute for Advanced Biosciences, Keio University
Items this document does not state (11)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage history

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The results are positioned as contributing to the expansion of the research foundation concerning the relationship between the gut environment, immunity and eye health, with the aim of leading to the creation of healthcare solutions in the future.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Suggesting that differences among bone marrow donors may affect the engraftment of gut bacteria following gut microbiota transplantation | Tsubota Laboratory Incorporated (4890) timely disclosure | Komori